Skip to Content
Merck
  • Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin.

Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin.

Bioorganic & medicinal chemistry (2009-11-03)
Lucie Guetzoyan, Xiao-Min Yu, Florence Ramiandrasoa, Stéphanie Pethe, Christophe Rogier, Bruno Pradines, Thierry Cresteil, Martine Perrée-Fauvet, Jean-Pierre Mahy
ABSTRACT

A series of acridine derivatives were synthesised and their in vitro antimalarial activity was evaluated against one chloroquine-susceptible strain (3D7) and three chloroquine-resistant strains (W2, Bre1 and FCR3) of Plasmodium falciparum. Structure-activity relationship showed that two positives charges as well as 6-chloro and 2-methoxy substituents on the acridine ring were required to exert a good antimalarial activity. The best compounds possessing these features inhibited the growth of the chloroquine-susceptible strain with an IC(50)0.07 microM, close to that of chloroquine itself, and that of the three chloroquine-resistant strains better than chloroquine with IC(50)0.3 microM. These acridine derivatives inhibited the formation of beta-hematin, suggesting that, like CQ, they act on the haem crystallization process. Finally, in vitro cytotoxicity was also evaluated upon human KB cells, which showed that one of them 9-(6-ammonioethylamino)-6-chloro-2-methoxyacridinium dichloride 1 displayed a promising antimalarial activity in vitro with a quite good selectivity index versus mammalian cell on the CQ-susceptible strain and promising selectivity on other strains.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
6,9-Dichloro-2-methoxyacridine, 97%